MRK
Merck & Co., Inc.
- Capital expenditures, 2025
- $4.1B
- YoY, 2025
- +21.9%
- 5-year CAGR
- −1.5%
- 10-year CAGR
- +12.4%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $4.1B | +21.9% |
| 2024 | $3.4B | −12.7% |
| 2023 | $3.9B | −12.0% |
| 2022 | $4.4B | −1.3% |
| 2021 | $4.4B | +0.4% |
| 2020 | $4.4B | +31.5% |
| 2019 | $3.4B | +28.8% |
| 2018 | $2.6B | +38.5% |
| 2017 | $1.9B | +17.0% |
| 2016 | $1.6B | +25.8% |
| 2015 | $1.3B | −2.6% |
| 2014 | $1.3B | −14.9% |
| 2013 | $1.5B | −20.8% |
| 2012 | $2.0B | +13.4% |
| 2011 | $1.7B | +2.7% |
| 2010 | $1.7B | +14.9% |
| 2009 | $1.5B | +12.6% |
| 2008 | $1.3B | +28.4% |
| 2007 | $1.0B | — |